Daniel Arias
Stock Analyst at Stifel
(5.00)
# 5
Out of 4,843 analysts
153
Total ratings
53.93%
Success rate
146.55%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $57 → $48 | $36.70 | +30.79% | 7 | May 8, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $48.40 | +23.97% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $40.62 | +47.71% | 3 | May 1, 2025 | |
| AVTR Avantor | Downgrades: Hold | $26 → $14 | $12.91 | +8.44% | 9 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $402.82 | +53.91% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $189.90 | +36.91% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.38 | +278.15% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $9.53 | +88.88% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $5.69 | +5.54% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,155.52 | +25.48% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $55.18 | +17.80% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $56.28 | +19.05% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $349.24 | +3.08% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $111.92 | +34.92% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $45.13 | +2.70% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.25 | +344.44% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $118.07 | +75.32% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $90.42 | +21.65% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $82.24 | +143.19% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.30 | +117.39% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.65 | +277.36% | 2 | May 31, 2022 |
Bruker
May 8, 2025
Maintains: Hold
Price Target: $57 → $48
Current: $36.70
Upside: +30.79%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $48.40
Upside: +23.97%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $40.62
Upside: +47.71%
Avantor
Apr 28, 2025
Downgrades: Hold
Price Target: $26 → $14
Current: $12.91
Upside: +8.44%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $402.82
Upside: +53.91%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $189.90
Upside: +36.91%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.38
Upside: +278.15%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $9.53
Upside: +88.88%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $5.69
Upside: +5.54%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,155.52
Upside: +25.48%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $55.18
Upside: +17.80%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $56.28
Upside: +19.05%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $349.24
Upside: +3.08%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $111.92
Upside: +34.92%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $45.13
Upside: +2.70%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.25
Upside: +344.44%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $118.07
Upside: +75.32%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $90.42
Upside: +21.65%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $82.24
Upside: +143.19%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.30
Upside: +117.39%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.65
Upside: +277.36%